MétaCan
Menu
Back to cohort
Record W2138535275 · doi:10.1002/mds.20243

Levodopa in the treatment of Parkinson's disease: Current controversies

2004· review· en· W2138535275 on OpenAlexaff
C. Warren Olanow, Yves Agid, Yoshi Mizuno, Alberto Albanese, U Bonucelli, Philip Damier, Justo De Yebenes, Oscar S. Gershanik, Mark Guttman, Francisco Grandas, Mark Hallett, Ole Hornykiewicz, Peter Jenner, Regina Katzenschlager, William Langston, Peter A. LeWitt, Eldad Melamed, M. A. Mena, Patrick P. Michel, Catherine Mytilineou, José Á. Obeso, Werner Poewe, Niall Quinn, Rita Raisman‐Vozari, Ali H. Rajput, Olivier Rascol, Christina Sampaio, Fabrizio Stocchi

Bibliographic record

VenueMovement Disorders · 2004
Typereview
Languageen
FieldMedicine
TopicNeurological disorders and treatments
Canadian institutionsRoyal University HospitalUniversity of Toronto
Fundersnot available
KeywordsLevodopaParkinson's diseaseDopamineDopamine receptorClinical trialMedicinePsychologyNeuroscienceDiseasePharmacologyInternal medicine

Abstract

fetched live from OpenAlex

Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the "gold standard" against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor complications. Levodopa is toxic to cultured dopamine neurons, and this may be a problem in PD where there is evidence of oxidative stress in the nigra. However, there is little firm evidence to suggest that levodopa is toxic in vivo or in PD. Clinical trials have not clarified this situation. Levodopa is also associated with motor complications. Increasing evidence suggests that they are related, at least in part, to the short half-life of the drug (and its potential to induce pulsatile stimulation of dopamine receptors) rather than to specific properties of the molecule. Treatment strategies that provide more continuous stimulation of dopamine receptors provide reduced motor complications in MPTP monkeys and PD patients. These studies raise the possibility that more continuous and physiological delivery of levodopa might reduce the risk of motor complications. Clinical trials to test this hypothesis are underway. We review current evidence relating to these areas of controversy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0020.004
Science and technology studies0.0000.001
Scholarly communication0.0010.002
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.337
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations370
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueMovement DisordersSame topicNeurological disorders and treatmentsFrench-language works237,207